Peter Harris

Executive Officer, Director at CND Life Sciences.

CND Life Sciences

Raised on CND Life Sciences filings

$15M

of $15.3M offered across 3 Form D filings

Form D filings: 3
Teammates: 5
Last filing: Aug 3, 2026

Company

CND Life Sciences

Healthcare

Skin biopsy test for Parkinson's disease

Skin biopsy test for Parkinson's disease

Investors: 27
Still open: $352K

Investors: 27
Sector: Healthcare

CND Life Sciences filings

CND Life Sciences Form D filings
Filed	Security	Sold of offered	Filing
Aug 3, 2026	Debt	$6.3M/ $6.3M	Form D/A
Jun 16, 2026	Debt	$4.3M/ $6.3M	Form D
May 6, 2025	Equity	$8.6M/ $9M	Form D/A

DebtFiled Aug 3, 2026Form D/A
$6.3M/ $6.3M
DebtFiled Jun 16, 2026Form D
$4.3M/ $6.3M
EquityFiled May 6, 2025Form D/A
$8.6M/ $9M

Works with

Also named on CND Life Sciences filings

Richard J. MorelloPresident/CEO, Form D signerForm D signer Jack SeaverDirector Christopher GibbonsDirector Enrique CarrazanaDirector Todd LevineExecutive Officer, Director